FTC warns drugmakers they can face legal action over improper patent listings
The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly list patents for brand-name medicines in a Food and Drug
The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly list patents for brand-name medicines in a Food and Drug
Gostin, Radhakrishnan, and Friedman are experts in health law and policy. The first Trump administration was marked by mismanagement of the COVID-19 pandemic and politicization
Researchers discuss the role of enhanced visceral adipose tissue metabolism in mediating weight loss by glucagon-like peptide-1 drugs.